---
figid: PMC5237710__gr2
figtitle: PI3K/Akt/mTOR pathway involved in tumorigenesis and metastasis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC5237710
filename: gr2.jpg
figlink: /pmc/articles/PMC5237710/figure/f0010/
number: F2
caption: PI3K/Akt/mTOR pathway involved in tumorigenesis and metastasis. After activation
  by RTKs, GPCR or RAS, PI3K catalyzes the phosphorylation of PIP2 to generate PIP3,
  which binds and recruits Akt and PDK1. Akt can be activated by PDK1 and mTORC2,
  after recruitment by PIP3. By increasing the level of cyclin D1, Akt promotes the
  cell cycle progression. Akt also acts to maintain cell survival by phosphorylation
  of BAD and release of the anti-apoptotic protein Bcl-2. Furthermore, Akt regulates
  cell growth by phosphorylation of the downstream mTORC1, which promotes translation
  of mRNAs to synthesize protein via p70S6K-S6 and 4E-BP1-eIF4E pathways. In addition,
  HIF-1α is up-regulated downstream of mTORC1, leading to angiogenesis. By activating
  NF-κB and inducing secretion of MMP, Akt promotes cell invasion. However, the mTORC1/S6K
  cascade negatively regulates IRS, which leads to a feedback loop. 4E-BP1, 4E-binding
  protein 1; GPCR, G protein-coupled receptor; GSK3β, glycogen synthesis kinase 3β;
  HIF-1, hypoxia-inducible factor 1; IRS, insulin receptor substrate; p70S6K, p70S6
  kinase; PDK1, 3-phosphoinositide-dependent protein kinase 1; RTK, receptor tyrosine
  kinase.
papertitle: Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy.
reftext: Wennan Zhao, et al. Acta Pharm Sin B. 2017 Jan;7(1):27-37.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9523173
figid_alias: PMC5237710__F2
figtype: Figure
redirect_from: /figures/PMC5237710__F2
ndex: d19e21c0-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5237710__gr2.html
  '@type': Dataset
  description: PI3K/Akt/mTOR pathway involved in tumorigenesis and metastasis. After
    activation by RTKs, GPCR or RAS, PI3K catalyzes the phosphorylation of PIP2 to
    generate PIP3, which binds and recruits Akt and PDK1. Akt can be activated by
    PDK1 and mTORC2, after recruitment by PIP3. By increasing the level of cyclin
    D1, Akt promotes the cell cycle progression. Akt also acts to maintain cell survival
    by phosphorylation of BAD and release of the anti-apoptotic protein Bcl-2. Furthermore,
    Akt regulates cell growth by phosphorylation of the downstream mTORC1, which promotes
    translation of mRNAs to synthesize protein via p70S6K-S6 and 4E-BP1-eIF4E pathways.
    In addition, HIF-1α is up-regulated downstream of mTORC1, leading to angiogenesis.
    By activating NF-κB and inducing secretion of MMP, Akt promotes cell invasion.
    However, the mTORC1/S6K cascade negatively regulates IRS, which leads to a feedback
    loop. 4E-BP1, 4E-binding protein 1; GPCR, G protein-coupled receptor; GSK3β, glycogen
    synthesis kinase 3β; HIF-1, hypoxia-inducible factor 1; IRS, insulin receptor
    substrate; p70S6K, p70S6 kinase; PDK1, 3-phosphoinositide-dependent protein kinase
    1; RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gpbar1
  - Ecm1
  - Ppp1r13b
  - Pik3ca
  - Pten
  - Pik3r1
  - Pdk1
  - Pdpk1
  - ras
  - Hras
  - Kras
  - Rem1
  - Akt1
  - Zhx2
  - Crtc1
  - Mdk
  - Gsk3b
  - Nfkb1
  - Eif4ebp1
  - Rps6kb1
  - Bad
  - Ccnd1
  - Bcl2
  - Eif4e
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PDK1
  - PDPK1
  - KRAS
  - HRAS
  - NRAS
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - CRTC1
  - RPTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - GSK3B
  - NFKB1
  - EIF4EBP1
  - RPS6KB1
  - BAD
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - CCND1
  - BCL2
  - EIF4E
  - EIF4E2
  - EIF4E3
  - SETD2
  - Tas2r134
  - Rxfp2
  - Pik3cg
  - Ccne1
  - Oamb
  - Tie
  - Ras85D
  - InR
  - IRSp53
  - IleRS
  - chico
  - Myb
  - Pi3K21B
  - Taf5
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Pi3K59F
  - Pi3K68D
  - Ras64B
  - Akt
  - Raf
  - Crtc
  - Tor
  - Dsor1
  - Mtk
  - sgg
  - Axn
  - gskt
  - Dif
  - dl
  - Rel
  - Thor
  - S6k
  - cass
  - MKP-4
  - p38b
  - rl
  - Mmp1
  - Debcl
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - tgo
  - sima
  - CycE
  - cyc
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
